Literature DB >> 19318512

High serum testosterone levels are associated with excessive erythrocytosis of chronic mountain sickness in men.

Gustavo F Gonzales1, Manuel Gasco, Vilma Tapia, Cynthia Gonzales-Castañeda.   

Abstract

Chronic mountain sickness (CMS) is characterized by excessive erythrocytosis (EE) secondary to hypoventilation. Erythropoietin (Epo) and testosterone regulate erythrocyte production. Low thyroid hormone levels are also associated to hypoventilation. Hence, these hormones can play a role in etiopathogeny of EE. The purpose of this study was to elucidate the effect of sexual and thyroid hormones and Epo in residents from Lima (150 m) and Cerro de Pasco (4,340 m), Peru, and the response to human chorionic gonadotrophin stimulation (hCG). Three groups, one at low altitude and two at high altitude [1 with hemoglobin values >16-21 g/dl and the second with Hb >or=21 g/dl (EE)], were studied. hCG was administered intramuscularly in a single dose (1,000 IU), and blood samples were obtained at 0, 6, 12, 24, 48, and 72 h after injection. High-altitude natives present similar levels of gonadotropins and thyroid hormones but lower dehydroepiandrosterone sulphate (DHEAS) levels (P < 0.01) and greater Epo (P < 0.01), 17alpha-hydroxyprogesterone (P < 0.01), and testosterone levels (P < 0.01) than those at 150 m. Serum testosterone levels (524.13 +/- 55.91 microg/dl vs. 328.14 +/- 53.23 ng/dl, means +/- SE; P < 0.05) and testosterone/DHEAS ratios are higher (7.98 +/- 1.1 vs. 3.65 +/- 1.1; P < 0.01) and DHEAS levels lower in the EE group (83.85 +/- 14.60 microg/dl vs. 148.95 +/- 19.11 ug/dl; P < 0.05), whereas Epo was not further affected. Testosterone levels were highest and DHEAS levels lowest in the EE group at all times after hCG stimulation. In conclusion, high androgen activity could be involved in the etiopathogeny of CMS. This evidence provides an opportunity to develop new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318512      PMCID: PMC2692401          DOI: 10.1152/ajpendo.90940.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  54 in total

1.  Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation.

Authors:  Tarja Saaresranta; Päivi Polo-Kantola; Irina Virtanen; Tero Vahlberg; Kerttu Irjala; Olli Polo
Journal:  Maturitas       Date:  2006-05-03       Impact factor: 4.342

2.  Testosterone and estradiol among older men.

Authors:  Eric Orwoll; Lori C Lambert; Lynn M Marshall; Kathy Phipps; Janet Blank; Elizabeth Barrett-Connor; Jane Cauley; Kris Ensrud; Steve Cummings
Journal:  J Clin Endocrinol Metab       Date:  2005-12-20       Impact factor: 5.958

3.  Effect of hypoxia on the release of vascular endothelial growth factor and testosterone in mouse TM3 Leydig cells.

Authors:  Guey-Shyang Hwang; Shyi-Wu Wang; Wen-Min Tseng; Ching-Han Yu; Paulus S Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-20       Impact factor: 4.310

4.  Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons.

Authors:  Yoshihiko Yamada; Hisahiko Sekihara; Masao Omura; Toshihiko Yanase; Ryoichi Takayanagi; Tomoatsu Mune; Keigo Yasuda; Tatsuo Ishizuka; Hajime Ueshiba; Yukitaka Miyachi; Tomoyuki Iwasaki; Atsushi Nakajima; Hajime Nawata
Journal:  Endocr J       Date:  2006-12-21       Impact factor: 2.349

Review 5.  The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness.

Authors:  Dante Penaloza; Javier Arias-Stella
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

Review 6.  Turning cells red: signal transduction mediated by erythropoietin.

Authors:  Terri D Richmond; Manprit Chohan; Dwayne L Barber
Journal:  Trends Cell Biol       Date:  2005-03       Impact factor: 20.808

7.  Reduced testosterone levels in males with lone atrial fibrillation.

Authors:  Jiangtao Lai; Dongchen Zhou; Shudong Xia; Yunpeng Shang; Lihong Want; Liangrong Zheng; Jianhua Zhu
Journal:  Clin Cardiol       Date:  2009-01       Impact factor: 2.882

8.  The effects of androstenedione on renal tubule epithelial cells.

Authors:  Hamed Benghuzzi; Adel Mohamed
Journal:  Biomed Sci Instrum       Date:  2007

9.  Sleep apnea syndrome and snoring in patients with hypothyroidism with relation to overweight.

Authors:  M Misiolek; B Marek; G Namyslowski; W Scierski; K Zwirska-Korczala; Z Kazmierczak-Zagorska; D Kajdaniuk; H Misiolek
Journal:  J Physiol Pharmacol       Date:  2007-03       Impact factor: 3.011

10.  Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis.

Authors:  Franco Scinicariello; H Edward Murray; Daphne B Moffett; Henry G Abadin; Mary J Sexton; Bruce A Fowler
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

View more
  15 in total

Review 1.  New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness.

Authors:  Francisco C Villafuerte
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

3.  High serum zinc and serum testosterone levels were associated with excessive erythrocytosis in men at high altitudes.

Authors:  Gustavo F Gonzales; Vilma Tapia; Manuel Gasco; Julio Rubio; Cynthia Gonzales-Castañeda
Journal:  Endocrine       Date:  2011-05-07       Impact factor: 3.633

4.  [Environmental pollution, climate variability and climate change: a review of health impacts on the Peruvian population].

Authors:  Gustavo F Gonzales; Alisson Zevallos; Cynthia Gonzales-Castañeda; Denisse Nuñez; Carmen Gastañaga; César Cabezas; Luke Naeher; Karen Levy; Kyle Steenland
Journal:  Rev Peru Med Exp Salud Publica       Date:  2014 Jul-Sep

5.  Association of Smoking with the Blood Concentration of 25-Hydroxy Vitamin D and Testosterone at High and Low Altitudes.

Authors:  Gaffar Sarwar Zaman; Safar Abadi Saeed Al-Saleem Alshahrani; Nasrin Banu Laskar; Ibrahim Hadadi; Magbool Alelyani; Mohamed Adam; Mohammed Babiker; Mustafa Jafar Musa; Pranab Barua; Mohammed Elimam Ahamed Mohammed
Journal:  Int J Gen Med       Date:  2022-02-07

Review 6.  Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes.

Authors:  Gustavo F Gonzales
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

7.  Noninvasive Assessment of Excessive Erythrocytosis as a Screening Method for Chronic Mountain Sickness at High Altitude.

Authors:  Kaetan J Vyas; David Danz; Robert H Gilman; Robert A Wise; Fabiola León-Velarde; J Jaime Miranda; William Checkley
Journal:  High Alt Med Biol       Date:  2015-05-14       Impact factor: 1.981

8.  Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness.

Authors:  Francisco C Villafuerte; José Luis Macarlupú; Cecilia Anza-Ramírez; Daniela Corrales-Melgar; Gustavo Vizcardo-Galindo; Noemí Corante; Fabiola León-Velarde
Journal:  J Appl Physiol (1985)       Date:  2014-10-16

9.  Potential beneficial effects of oral administration of isoflavones in patients with chronic mountain sickness.

Authors:  Jianhua Cui; Liang Gao; Haijun Yang; Fuling Wang; Chunhua Jiang; Yuqi Gao
Journal:  Exp Ther Med       Date:  2013-11-07       Impact factor: 2.447

10.  The association between the levels of serum ferritin and sex hormones in a large scale of Chinese male population.

Authors:  Zhenfang Liu; Fanghui Ye; Haiying Zhang; Yong Gao; Aihua Tan; Shijun Zhang; Qiang Xiao; Bing Zhang; Lulu Huang; Bingbing Ye; Xue Qin; Chunlei Wu; Zheng Lu; Youjie Zhang; Ming Liao; Xiaobo Yang; Zengnan Mo
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.